{"title":"Tetrachlorobisphenol A Induces Programmed Cell Death and Senescence in Vascular Endothelial Cells","authors":"Huanyu Qiao, Bo Yang, Xiaoshuo Lv, Yongmin Liu","doi":"10.1002/cbin.70121","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Tetrachlorobisphenol A (TCBPA) is an organic compound extensively utilized in industrial production as an alternative to Tetrabromobisphenol A (TBBPA). Currently, TCBPA has been frequently detected in various environmental media. TCBPA residues have been detected in environmental samples, prompting concerns about its potential toxicological impact on human health. This study focuses on the potential impact of TCBPA on vascular health, particularly its effects on vascular endothelial cells. Through CCK8 and EdU assays, we observed that TCBPA treatment inhibited the proliferation of vascular endothelial cells. Further studies showed that TCBPA triggers an inflammatory response in vascular endothelial cells, including IL-6, IL-1β, and TNF-α. Additionally, TCBPA was found to trigger oxidative stress in vascular endothelial cells, as evidenced by increased levels of reactive oxygen species (ROS). Further studies demonstrated that TCBPA led to programmed necrosis and senescence in vascular endothelial cells. Mechanistically, we discovered that ROS-induced mitochondrial Z-DNA played a critical role in this process. Our findings suggest that TCBPA may inhibit vascular endothelial cell proliferation, posing a potential risk for vascular damage. This study highlights the importance of regulating TCBPA usage to minimize potential health risks.</p>\n </div>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 2","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Biology International","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cbin.70121","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Tetrachlorobisphenol A (TCBPA) is an organic compound extensively utilized in industrial production as an alternative to Tetrabromobisphenol A (TBBPA). Currently, TCBPA has been frequently detected in various environmental media. TCBPA residues have been detected in environmental samples, prompting concerns about its potential toxicological impact on human health. This study focuses on the potential impact of TCBPA on vascular health, particularly its effects on vascular endothelial cells. Through CCK8 and EdU assays, we observed that TCBPA treatment inhibited the proliferation of vascular endothelial cells. Further studies showed that TCBPA triggers an inflammatory response in vascular endothelial cells, including IL-6, IL-1β, and TNF-α. Additionally, TCBPA was found to trigger oxidative stress in vascular endothelial cells, as evidenced by increased levels of reactive oxygen species (ROS). Further studies demonstrated that TCBPA led to programmed necrosis and senescence in vascular endothelial cells. Mechanistically, we discovered that ROS-induced mitochondrial Z-DNA played a critical role in this process. Our findings suggest that TCBPA may inhibit vascular endothelial cell proliferation, posing a potential risk for vascular damage. This study highlights the importance of regulating TCBPA usage to minimize potential health risks.
期刊介绍:
Each month, the journal publishes easy-to-assimilate, up-to-the minute reports of experimental findings by researchers using a wide range of the latest techniques. Promoting the aims of cell biologists worldwide, papers reporting on structure and function - especially where they relate to the physiology of the whole cell - are strongly encouraged. Molecular biology is welcome, as long as articles report findings that are seen in the wider context of cell biology. In covering all areas of the cell, the journal is both appealing and accessible to a broad audience. Authors whose papers do not appeal to cell biologists in general because their topic is too specialized (e.g. infectious microbes, protozoology) are recommended to send them to more relevant journals. Papers reporting whole animal studies or work more suited to a medical journal, e.g. histopathological studies or clinical immunology, are unlikely to be accepted, unless they are fully focused on some important cellular aspect.
These last remarks extend particularly to papers on cancer. Unless firmly based on some deeper cellular or molecular biological principle, papers that are highly specialized in this field, with limited appeal to cell biologists at large, should be directed towards journals devoted to cancer, there being very many from which to choose.